FENFURO™ is a proprietary product derived from Fenugreek seeds (Trigonella Foenum Graecum) by an innovative process. It is a group of furostanolic saponins that help to maintain healthy blood glucose levels. FENFURO contains a rich variety of saponins and flavonoids. All of these substances are known to play valuable role in maintaining a stable Glucose levels.
Fenfuro is supported by 7 international patents and has also been clinically evaluated on 254 diabetic patients. A further study on 100 patients is underway at AIIMS. The clinical studies have been published in well-known international journals and have won awards in many international conferences.
It is an Over the Counter (OTC) product and has been approved by FSSAI.